Article metrics

Download PDFPDF
CP-123 A cost effectiveness analysis of nivolumab compared with pemetrexed for the treatment of non-small cell lung cancer in real practice

 

Online download statistics by month:

Online download statistics by month: February 2017 to September 2024

AbstractFullPdf
Feb 2017200
Mar 20171305
Apr 2017200
May 20171200
Jun 2017400
Jul 20172000
Aug 2017400
Sep 20172002
Oct 2017400
Nov 20173400
Dec 20173000
Jan 20182201
Feb 20181600
Mar 20182800
Apr 20188201
May 20183600
Jun 20183600
Jul 2018800
Aug 20182000
Sep 20181800
Oct 20181400
Nov 20183200
Dec 2018800
Jan 20192200
Feb 20192300
Mar 20191401
Apr 20191401
May 20191000
Jun 20192602
Jul 20191401
Aug 2019800
Sep 2019600
Oct 20191600
Nov 20191000
Dec 2019602
Jan 20201202
Feb 2020600
Mar 2020600
Apr 20201500
May 2020400
Jun 2020600
Jul 20201400
Aug 20201200
Sep 2020400
Oct 2020400
Nov 2020900
Dec 2020200
Jan 2021600
Mar 2021100
Oct 2021200
Nov 20211400
Dec 20211800
Jan 2022200
Feb 2022400
Mar 2022600
Apr 20222000
May 20222600
Jun 20223000
Jul 20221700
Aug 20221400
Sep 20222100
Oct 2022900
Nov 20221400
Dec 20221400
Jan 20231000
Feb 20231400
Mar 20231800
Apr 2023200
May 2023200
Jul 2023403
Sep 2023200
Oct 2023200
Nov 2023400
Dec 20231600
Jan 2024300
Feb 2024200
Mar 2024400
Apr 2024600
May 2024800
Jun 2024200
Jul 20241000
Aug 20245601
Sep 2024800
Total1119022